Interferon-β-1a slows down progression of brain atrophy in relapsing-remitting multiple sclerosis by reducing predominantly grey matter atrophy progression

被引：0
|
作者：
Zivadinov, R
Locatelli, L
Srinivasuraghavan, B
Ukmar, M
Bratina, A
Maggiore, G
Bosco, A
Grop, A
Pozzi-Mucelli, BS
Catalan, M
Zorzon, M
机构：
[1] Univ Buffalo, Buffalo, NY USA
[2] Univ Trieste, I-34127 Trieste, Italy
来源：
MULTIPLE SCLEROSIS | 2004年 / 10卷 / 7032期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S243 / S243
页数：1
相关论文
共 50 条
  • [21] Spotlight on subcutaneous recombinant interferon-β-1a (Rebif®) in relapsing-remitting multiple sclerosis
    Murdoch, D
    Lyseng-Williamson, KA
    BIODRUGS, 2005, 19 (05) : 323 - 325
  • [22] Therapeutic strategies for relapsing-remitting multiple sclerosis: a special focus on reduction of grey matter damage as measured by brain atrophy
    Calabrese, Massimiliano
    Gajofatto, Alberto
    Benedetti, Maria Donata
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2014, 14 (12) : 1417 - 1428
  • [23] Brain atrophy is age-related in relapsing-remitting multiple sclerosis
    Kacar, Sezgi
    Coerver, Eline
    Schoonheim, Menno
    Koch, Marcus
    Mostert, Jop
    Killestein, Joep
    Sormani, Maria Pia
    Ciccarelli, Olga
    Arnold, Douglas L.
    Barkhof, Frederik
    Uitdehaag, Bernard
    Eshaghi, Arman
    Strijbis, Eva
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 13 - 14
  • [24] Use of the FIM™ instrument in a trial of intramuscular interferon β-1a for disease progression in relapsing-remitting multiple sclerosis
    Granger, CV
    Wende, K
    Brownscheidle, CM
    AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION, 2003, 82 (06) : 427 - 436
  • [25] Regional grey matter atrophy is largely unrelated to white matter tissue loss in relapsing-remitting multiple sclerosis
    Riccitelli, G.
    Rocca, M. A.
    Pagani, E.
    Martinelli, V.
    Radaelli, M.
    Falini, A.
    Comi, G.
    Filippi, M.
    JOURNAL OF NEUROLOGY, 2011, 258 : 41 - 42
  • [26] Treating relapsing-remitting multiple sclerosis: therapy effects on brain atrophy
    Vidal-Jordana, Angela
    Sastre-Garriga, Jaume
    Rovira, Alex
    Montalban, Xavier
    JOURNAL OF NEUROLOGY, 2015, 262 (12) : 2617 - 2626
  • [27] Effect of intravenous methylprednisolone on brain atrophy in relapsing-remitting multiple sclerosis
    Zivadinov, R
    Rudick, RA
    De Masi, R
    Nasuelli, D
    Ukmar, M
    Pozzi-Mucelli, RS
    Grop, A
    Cazzato, G
    Zorzon, M
    NEUROLOGY, 2001, 56 (08) : A192 - A192
  • [28] Brain atrophy in relapsing-remitting multiple sclerosis:: Fractional volumetric analysis of gray matter and white matter
    Ge, YL
    Grossman, RI
    Udupa, JK
    Babb, JS
    Nyúl, LG
    Kolson, DL
    RADIOLOGY, 2001, 220 (03) : 606 - 610
  • [29] Interferon-beta and disability progression in relapsing-remitting multiple sclerosis
    Drulovic, Jelena
    Kostic, Jelena
    Mesaros, Sarlota
    Basuroski, Irena Dujmovic
    Stojsavljevic, Nebojsa
    Kisic-Tepavcevic, Darija
    Pekmezovic, Tatjana
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2013, 115 : S65 - S69
  • [30] Recombinant interferon-β-1a -: A review of its therapeutic efficacy in relapsing-remitting multiple sclerosis
    Wagstaff, AJ
    Goa, KL
    BIODRUGS, 1998, 10 (06) : 471 - 494
12345